Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Sees Significant Decline in Short Interest

Advanced Medical Isotope Corporation (OTCMKTS:RDGLGet Free Report) saw a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 142,100 shares, a drop of 65.1% from the June 15th total of 407,416 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 2,234,493 shares, the days-to-cover ratio is currently 0.1 days.

Advanced Medical Isotope Stock Down 3.7%

OTCMKTS:RDGL opened at $0.06 on Wednesday. Advanced Medical Isotope has a twelve month low of $0.04 and a twelve month high of $0.15. The company has a fifty day moving average of $0.07 and a 200-day moving average of $0.07. The firm has a market capitalization of $28.06 million, a P/E ratio of -5.68 and a beta of -0.75.

About Advanced Medical Isotope

(Get Free Report)

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.

See Also

Receive News & Ratings for Advanced Medical Isotope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Isotope and related companies with MarketBeat.com's FREE daily email newsletter.